BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38489717)

  • 1. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
    Wu N
    Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
    Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
    Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a prognostic nomogram for lymph node positive HR
    Cheng X; Jiang J; Liang X; Zheng X
    Gland Surg; 2023 Nov; 12(11):1541-1553. PubMed ID: 38107492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
    Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
    Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prognostic nomogram for predicting cancer-specific survival in lymph node-negative elderly esophageal cancer patients: A SEER-based study.
    Qin L; Chen L; Tie X; Guo X; Yang F; Liu Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34441. PubMed ID: 37505134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
    Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
    BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis.
    Yang R; Wu Y; Qi Y; Liu W; Huang Y; Zhao X; Chen R; He T; Zhong X; Li Q; Zhou L; Chen J
    BMC Geriatr; 2023 Sep; 23(1):594. PubMed ID: 37749538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.
    Wang H; Xia GF; Zhang ZR; Luo X; Zhu JY; Wang HK
    Am J Cancer Res; 2023; 13(11):5065-5081. PubMed ID: 38058820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram model for predicting cancer-specific mortality in patients with early-onset colorectal cancer: a competing risk analysis insight from the SEER database and an external validation cohort.
    Fu X; Chen Y; Fan Z; Wang W; Wang Z; Yin H; Li J; Guo S
    Transl Cancer Res; 2024 Apr; 13(4):1665-1684. PubMed ID: 38737689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study.
    Wu J; Xie Z; Xiao Y; Wang B; Zhang P
    Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: A retrospective cohort study.
    Lyu X; Luo B
    Cancer Med; 2021 Nov; 10(22):8114-8126. PubMed ID: 34612593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing risk nomogram for predicting cancer-specific mortality in patients with non-melanoma skin cancer.
    Tang L; Zhang L; Zeng Y; Li Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8817-8827. PubMed ID: 37142808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nomogram for predicting long-term heart-disease specific survival among older female primary breast cancer patients that underwent chemotherapy: A real-world data retrospective cohort study.
    Huang C; Ding Z; Li H; Zhou Z; Yu M
    Front Public Health; 2022; 10():964609. PubMed ID: 36091523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Zhao J; Bian S; Di X; Xiao C
    Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram for predicting cancer-specific survival for elderly patients with gallbladder cancer.
    Wen C; Tang J; Wang T; Luo H
    BMC Gastroenterol; 2022 Nov; 22(1):444. PubMed ID: 36324087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
    Li Y; Chen T; Fu B; Luo Y; Chen L
    Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for hormone receptor-positive breast cancer with liver metastasis and establishment of novel nomograms for prediction: a SEER-based study.
    Xu Z; Chen Y; Dai Y; Chen Y; Ding J
    Transl Cancer Res; 2023 Dec; 12(12):3672-3692. PubMed ID: 38193003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
    Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
    Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.